PHARMACYTE BIOTECH, INC. (PMCB) Shareholders’ equity 2017–2026
PHARMACYTE BIOTECH, INC. (PMCB) shareholders’ equity at each fiscal year-end, per SEC filings.
$33.3MFY2026 · since FY2017: $8.1M → $33.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $33.3M | -35.8% |
| FY2025 | $51.9M | +87.7% |
| FY2024 | $27.6M | -62.0% |
| FY2023 | $72.7M | -19.2% |
| FY2022 | $89.9M | +1246.2% |
| FY2021 | $6.7M | +31.3% |
| FY2020 | $5.1M | +1.0% |
| FY2019 | $5.0M | -12.6% |
| FY2018 | $5.8M | -28.7% |
| FY2017 | $8.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice